Membrane-type 1 Matrix Metalloproteinase in COPD
COPD 中的膜 1 型基质金属蛋白酶
基本信息
- 批准号:7656595
- 负责人:
- 金额:$ 12.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-11 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAdvisory CommitteesAffectAgeAge-MonthsAlveolarAlveolar MacrophagesAlveolar wallAnimalsApplications GrantsAreaArthritisBasement membraneBindingBiological MarkersBirthBlood - brain barrier anatomyBody WeightBone GrowthBone Marrow TransplantationCD44 AntigensCD44 geneCause of DeathCell Adhesion MoleculesCell Surface ProteinsCell membraneCell surfaceCellsCellular biologyChondrocytesChronicChronic Obstructive Airway DiseaseCigarette smoke-induced emphysemaClara cellCleaved cellClinicalCollagenComplexDefectDevelopmentDiseaseDrosophila pros proteinDuct (organ) structureElastasesEndothelial CellsEnvironmentEpithelialEpithelial CellsEpitheliumExtracellular MatrixFailureFamilyFibrillar CollagenFibroblastsFutureGelGelatinase AGrowthHemopexinHumanIn VitroIndividualInflammationInflammatoryInjuryIntegrinsInterstitial CollagenaseKnowledgeKyphosis deformity of spineLaboratoriesLamininLengthLigandsLungLung InflammationLung diseasesMalignant NeoplasmsMatrix MetalloproteinasesMediatingMethodsModificationMolecular Biology TechniquesMolecular and Cellular BiologyMorphogenesisMultiple SclerosisMusNaphthaleneNaphthalenesNeoplasm MetastasisPathogenesisPathologicPatientsPeptide HydrolasesPeripheralPhysiciansPhysiologicalPlayPrincipal InvestigatorProductionProtein C InhibitorProteinsPulmonary EmphysemaRecyclingResearchResearch PersonnelRodentRoleScientistSiteSmokeSurfaceTechnologyTemperatureTissue Inhibitor of Metalloproteinase-1TissuesTransgenic MiceTransgenic OrganismsTransglutaminasesUniversitiesUp-RegulationWashingtonWorkairway remodelingalveolar type II cellbasecancer cellcareercareer developmentcell motilitycigarette smoke-inducedcigarette smokingcoated pitcollagenaseenzyme activityhuman MMP14 proteinin vivoinjury and repairinterestinterstitiallong bonelung developmentlung injurymacrophagemembrane-type matrix metalloproteinasemigrationmonocytemouse modelnoveloverexpressionperipheral bloodpostnatalprogramsrole modelskeletal abnormalityskillswasting
项目摘要
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a disease of major proportion and a critical target for future research. The development of new investigators with expertise in ths field will be an essential step in progress towards our understanding of the pathogenesis and treatment of COPD. This grant proposal requests support for the transition in my career from a clinical scientist with knowledge in molecular and cellular biology of lung disorders into an independent investigator with a focus in utilizing molecular biology techniques in protease-mediated lung disorders, such as COPD. For the past several decades, the development of COPD has been attributed to cigarette smoke induced-inflammation and elastase production, but recently collagenases have been implicated in the development of emphysema. I have found that membrane-type 1 matrix metalloproteinase (MT1-MMP), a collagenase, is expressed by alveolar macrophages and airway epithelial cells in a mouse model of cigarette smoke exposure induced-COPD and in the airway after naphthalene-induced acute airway epithelial injury, suggesting it plays a role in lung injury and repair. Based on these observations, I hypothesize that MT1-MMP is involved in the pathogenesis of COPD. I will examine alveolar wall destruction, airway remodeling, macrophage migration and inflammation in the presence and absence of MT1-MMP to determine the role and consequences of MT1-MMP production that occurs during cigarette smoke exposure. The work proposed in this application will be performed at Washington University in the laboratory of Dr. Robert Senior in conjunction with an Advisory Committee composed of experts in the fields of transgenic mouse technologies, epithelial cell biology and extracellular matrix. This is an environment that has proven successful in the development of physician scientists for research careers. In addition to uncovering a novel target in the treatment of COPD, this proposal will provide career development, so that I will attain skills to do COPD research independently.
描述(申请人提供):慢性阻塞性肺疾病(COPD)是一种占很大比例的疾病,也是未来研究的关键目标。具有该领域专业知识的新研究人员的发展将是我们在了解COPD的发病机制和治疗方面取得进展的重要一步。这项拨款提案要求支持我在职业生涯中从一名在肺部疾病的分子和细胞生物学方面拥有知识的临床科学家转变为一名独立的研究员,专注于利用蛋白质酶介导的肺部疾病(如慢性阻塞性肺病)的分子生物学技术。在过去的几十年里,COPD的发展被归因于吸烟引起的炎症和弹性蛋白酶的产生,但最近胶原酶被认为与肺气肿的发展有关。笔者发现,在香烟烟雾致COPD小鼠模型中,肺泡巨噬细胞和呼吸道上皮细胞表达胶原酶-1型基质金属蛋白酶(MT1-MMPs),在萘诱导的急性呼吸道上皮损伤后的气道中也有表达,提示其在肺损伤修复中起一定作用。基于这些观察,我推测MT1-MMPs参与了COPD的发病机制。我将研究有无MT1-MMP时的肺泡壁破坏、气道重塑、巨噬细胞迁移和炎症,以确定在香烟烟雾暴露期间MT1-MMPs产生的作用和后果。这项申请中提出的工作将在华盛顿大学罗伯特博士的实验室与一个由转基因小鼠技术、上皮细胞生物学和细胞外基质领域的专家组成的咨询委员会一起进行。这是一个已被证明在培养内科科学家从事研究事业方面取得成功的环境。除了揭示COPD治疗的新靶点外,这项提议还将为我的职业发展提供帮助,使我获得独立从事COPD研究的技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY J ATKINSON其他文献
JEFFREY J ATKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY J ATKINSON', 18)}}的其他基金
MOLECULAR MECHANISMS OF CHRONIC AIRWAY AND ALVEOLAR DISEASE IN HIV
HIV 慢性气道和肺泡疾病的分子机制
- 批准号:
8637535 - 财政年份:2013
- 资助金额:
$ 12.39万 - 项目类别:
MOLECULAR MECHANISMS OF CHRONIC AIRWAY AND ALVEOLAR DISEASE IN HIV
HIV 慢性气道和肺泡疾病的分子机制
- 批准号:
8743253 - 财政年份:2013
- 资助金额:
$ 12.39万 - 项目类别:
Membrane-type 1 Matrix Metalloproteinase in COPD
COPD 中的膜 1 型基质金属蛋白酶
- 批准号:
7531173 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Membrane-type 1 Matrix Metalloproteinase in COPD
COPD 中的膜 1 型基质金属蛋白酶
- 批准号:
8286947 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Membrane-type 1 Matrix Metalloproteinase in COPD
COPD 中的膜 1 型基质金属蛋白酶
- 批准号:
8094286 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Membrane-type 1 Matrix Metalloproteinase in COPD
COPD 中的膜 1 型基质金属蛋白酶
- 批准号:
7880083 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 12.39万 - 项目类别:
Research Grant














{{item.name}}会员




